Diagnosis Code C92.21
Information for Medical Professionals
The diagnosis code C92.21 is grouped in the following Diagnostic Related Group(s) (MS-DRG v33.0)
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC 820
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH CC 821
- LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC 822
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 205.21 - Sbac myl leuk w rmsion (approximate) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
Information for Patients
Also called: CML, Chronic granulocytic leukemia, Chronic myelogenous leukemia
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic myeloid leukemia (CML), there are too many granulocytes, a type of white blood cell.
Most people with CML have a gene mutation (change) called the Philadelphia chromosome.
Sometimes CML does not cause any symptoms. If you have symptoms, they may include:
- Weight loss
- Night sweats
- Pain or a feeling of fullness below the ribs on the left side
Tests that examine the blood and bone marrow diagnose CML. Treatments include chemotherapy, stem cell transplants, infusion of donated white blood cells following stem cell transplants, surgery to remove the spleen, and biologic and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute
- After chemotherapy - discharge
- Bone marrow transplant
- Bone marrow transplant - discharge
- Chronic myelogenous leukemia (CML)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)